Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep904 | Reproductive and Developmental Endocrinology | ECE2022

Development of ANA antibodies induced by estrogen treatment.

Medina Rivero Daniel , Gavira Isabel Mateo , Larran Escandon Laura

A 36-year-old woman in follow-up due to early ovarian failure of idiopathic origin. No family history of interest. History of menarche at 12 years of age with regular menses until 18 years of age, when it begins with amenorrheic spells lasting up to 8 months. Laboratory tests revealed hypergonadotropic hypogonadism with negative ovarian autoantibodies, normal karyotype, and gynecological ultrasound showing a normal-looking uterus with slight bilateral ovarian atrophy. Negative...

ea0041ep616 | Endocrine tumours and neoplasia | ECE2016

Clinical benefit of patients with advanced adrenocortical carcinoma (Acc) treated in phase I clinical trials: the royal marsden hospital (Rmh) experience

Custodio Ana , Lopez Juanita , de Bono Johann S

Introduction: After progression on conventional treatment options, some patients with advanced ACC are offered experimental Phase I therapies. The outcomes of these patients have not yet been formally evaluated. This study aims to describe the experience of refractory ACC patients treated on Phase I clinical trials at the RMH.Methods: We retrospectively reviewed the records of metastatic ACC patients consecutively treated in our Drug Development Unit bet...

ea0090p111 | Endocrine-related Cancer | ECE2023

Body composition of Patients with advanced Gastroenteropancreatic (GEP) Neuroendocrine Neoplasms (NENs) in Spain: Nutrigetne Study

Argente Pla Maria , Casteras Anna , Giribes Miguel , Anton Beatriz , Soledad Librizzi Maria , Custodio Carretero Ana , Palma Milla Samara , Suarez Gutierrez Lorena , Peiro Inmaculada , Serrano Urzaiz Leticia , Leon-Idougourram Soraya , Dieguez Felechosa Marta , Febrero Beatriz , Scorojanu Iulia , Antonio Pazos Toral Fernando , Biarnes Josefina , Pascual-Corrales Eider , Angel Dias-Perez Jose , Antonio Sampedro-Nunez Miguel , Angel Martinez Olmos Miguel , Mico Garcia Andrea , Isabel Del Olmo Garcia Maria

Introduction / Background: Patients with advanced GEP-NENs often present with metabolic disorders and oncological treatments may increase malnutrition risk as well as alterations on body composition. Several studies have suggested that sarcopenia is independently associated with a worse prognosis in oncological patients. Sarcopenia predicts survival regardless of body weight; moreover, a reduced muscle mass is not only observed in cachectic individuals but also in overweight p...

ea0037ep1337 | Clinical Cases–Thyroid/Other | ECE2015

Recurrent severe symptomatic hyponatraemia induced by low-dose oral cyclophosphamide in a patient with ANA-related vasculitis

Dineen Rosemary , Pazderska Agnieszka , Mullan Ronan , Gibney James , Sherlock Mark

Cyclophosphamide is an alkylating agent used in the treatment of malignant and autoimmune diseases. Severe hyponatraemia is a serious electrolyte disorder with life threatening neurological sequelae. We report a case of recurrent severe, symptomatic hyponatraemia that developed in a 61 year old female with systemic vasculitis and Sjogrens syndrome following low-dose cyclophosphamide.Case report: A 61 year old lady, with ANA positive systemic vasculitis p...

ea0023p12 | (1) | BSPED2009

The IGF system during acute hypoxia in children

Custodio Rodrigo , Custodio Viviane , Scrideli Carlos , Cervi Maria , Cupo Palmira , Martinelli Jr Carlos

The hypoxia, associated to intra-uterine growth restriction, is related to high concentrations of IGFBP1 and unchanged concentrations of IGF1 in animals. Nevertheless, during threatening life events, low IGFI concentrations and high IGFBP1 concentrations was reported. Furthermore, severe hypoxia increased the IGF1R expression of the neuronal growth cones in the ovine fetal brain. No information is available regarding the regulation of the IGF system by the acute hypoxia in hum...

ea0081p410 | Pituitary and Neuroendocrinology | ECE2022

Favorable liver safety profile of the selective glucocorticoid receptor modulator relacorilant in healthy and hepatically impaired adults and in patients with cushing syndrome

G. Moraitis Andreas , Custodio Joseph , Cristina Tudor Iulia

Background: Relacorilant is a highly selective glucocorticoid receptor (GR) modulator in development for the treatment of endogenous Cushing syndrome (CS). Unlike the GR antagonist mifepristone, relacorilant lacks affinity for the progesterone and other receptors. In a phase 2 study in patients with CS (Pivonello et al, 2021), relacorilant provided clinically meaningful changes in several cortisol-excess-related comorbidities, including hypertension and hyperglycemia,...

ea0023oc1.3 | Oral Communications 1 | BSPED2009

IGF1R gene expression in patients with idiopathic short stature according to GH and IGF1 status

Milani Soraya Sader , Custodio Rodrigo , Martinelli Carlos Eduardo

The aim of this study was to analyze IGF1R gene expression in patients with idiopathic short stature (ISS) and correlate it with their GH and IGF1 status. In a previous study, we reported lower final height in subjects with ISS and GH peak ≥40 mU/l (Group1, n=16) compared to those with ISS and GH peak between 20 and 40 mU/l (Group2, n=15), after stimulation test (ITT) performed before or during puberty. Patients were 16–24 (Group1) and 15–26 (Grou...

ea0032p793 | Paediatric endocrinology | ECE2013

Abnormalities in growth and in the IGF system can be associated to permanent chronic inflammatory process in HIV-infected children independently of clinical control

Ruiz Marcelo , Milani Soraya , Custodio Rodrigo , Negrini Bento , Celia Cervi Maria , Martinelli Carlos

Background: HIV-infected paediatric patients usually show impaired growth. Data reporting abnormalities in GH–IGF–IGFBPs system are scarce and inconclusive.Aim: To analyse blood concentration of the major components of IGF–IGFBPs system in these children and compare them to growth parameters and to cytokines levels.Methods: prepubertal HIV-infected children, aged 8.2±1.7 years, were evaluated every 6 months duri...

ea0049ep1467 | Thyroid (non-cancer) | ECE2017

Follicular thyroid carcinoma and follicular variant papillary thyroid carcinoma: Clinical and histological features depending on the initial size

Perez Fernando Garcia , Gordillo Guillermo Martinez de Pinillos , Fernandez-Ladreda Mariana Tome , Lloclla Eyvee Arturo Cuellar , Porcel Jose Alvaro Romero , Marin Carmen Carretero , Leon Maria Victoria Cozar

Introduction: Follicular Thyroid Carcinomas (FTCs) and Follicular Variant Papillary Thyroid Carcinomas (FVPTCs) may present absence of suspicious ultrasonography features more frequently than classic papillary carcinomas. Thus, some cases may be identified with the pattern of ‘low suspicion’ rather than intermediate or high suspicion defined in the American Thyroid Association (ATA) guidelines of 2015. These guidelines establish a size cutoff of 1.5 cm to recommend f...

ea0056ep175 | Thyroid | ECE2018

Cretinism and language delay are rare manifestations of central hypothyroidism: 2 cases report

Beldi Vinicius , Marson Tomas , Araujo Aiana , Siena Thais , de Paula Mariana , Atique Patricia , Custodio Rodrigo , Maciel Lea , Ferraz Ivan , Del Ciampo Luiz , Martinelli Carlos

Cretinism and neurological impairment are related to primary hypothyroidism (PHT) while children with central hypothyroidism (CHT) are usually diagnosed during the investigation process for short stature.Objective: To describe two children with unusual presentation of CHT.Case 1: Baby girl, born after 38 weeks of gestation, weighing 3000 g, and measuring 49.5 cm long was admitted when 3 months old. The parents reported stunted neur...